George Medicines Logo.JPG
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill
January 17, 2022 07:00 ET | George Medicines
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as part of global trial Investigational single-pill combination offers potential to...
George Medicines Logo.JPG
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill
January 17, 2022 02:00 ET | George Medicines
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as part of global trial Investigational single-pill combination offers potential to...
George Medicines Logo.JPG
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director
July 12, 2021 07:00 ET | George Medicines
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and...
George Medicines Logo.JPG
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director
July 12, 2021 02:00 ET | George Medicines
George Medicines appoints Dr Charmaine Gittleson as Non-Executive Director London, UK, 12 July 2021 – George Medicines, a late-stage drug development company focused on providing innovative and...
George Medicines Logo.JPG
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
July 01, 2021 07:00 ET | George Medicines
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...
George Medicines Logo.JPG
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension
July 01, 2021 02:00 ET | George Medicines
George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...
George Medicines Logo.JPG
George Medicines appoints Stefan König as Chief Executive Officer
June 03, 2021 07:00 ET | George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...
George Medicines Logo.JPG
George Medicines appoints Stefan König as Chief Executive Officer
June 03, 2021 02:00 ET | George Medicines
George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...